These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 34611400)

  • 1. Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment.
    Milewska S; Niemirowicz-Laskowska K; Siemiaszko G; Nowicki P; Wilczewska AZ; Car H
    Int J Nanomedicine; 2021; 16():6593-6644. PubMed ID: 34611400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational nanocarrier design towards clinical translation of cancer nanotherapy.
    Guo D; Ji X; Luo J
    Biomed Mater; 2021 Mar; 16(3):. PubMed ID: 33540386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in intelligent-responsive nanocarriers for cancer therapy.
    Tian M; Xin X; Wu R; Guan W; Zhou W
    Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of nanotechnology in drug delivery systems for respiratory diseases (Review).
    Luo MX; Hua S; Shang QY
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
    Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
    Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How nanotechnology can enhance docetaxel therapy.
    Zhang L; Zhang N
    Int J Nanomedicine; 2013; 8():2927-41. PubMed ID: 23950643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine.
    Kumar V; Rahman M; Gahtori P; Al-Abbasi F; Anwar F; Kim HS
    Expert Opin Drug Deliv; 2021 Jun; 18(6):673-694. PubMed ID: 33295218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
    Anchordoquy TJ; Barenholz Y; Boraschi D; Chorny M; Decuzzi P; Dobrovolskaia MA; Farhangrazi ZS; Farrell D; Gabizon A; Ghandehari H; Godin B; La-Beck NM; Ljubimova J; Moghimi SM; Pagliaro L; Park JH; Peer D; Ruoslahti E; Serkova NJ; Simberg D
    ACS Nano; 2017 Jan; 11(1):12-18. PubMed ID: 28068099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actively targeted nanocarriers for drug delivery to cancer cells.
    Biffi S; Voltan R; Bortot B; Zauli G; Secchiero P
    Expert Opin Drug Deliv; 2019 May; 16(5):481-496. PubMed ID: 30955393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.
    Moradi Kashkooli F; Soltani M; Souri M
    J Control Release; 2020 Nov; 327():316-349. PubMed ID: 32800878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Gelatin-Based Nanomedicine for Targeted Delivery of Anti-Cancer Drugs.
    Raza F; Siyu L; Zafar H; Kamal Z; Zheng B; Su J; Qiu M
    Curr Pharm Des; 2022; 28(5):380-394. PubMed ID: 34727851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress in nanomedicine for enhanced cancer chemotherapy.
    Wei G; Wang Y; Yang G; Wang Y; Ju R
    Theranostics; 2021; 11(13):6370-6392. PubMed ID: 33995663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
    Vangijzegem T; Stanicki D; Laurent S
    Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.